|
CCDC47 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54601999999837E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.26110000000057E-05 |
| Normal-vs-Stage2 |
5.714100E-02 |
| Normal-vs-Stage3 |
4.93239999999062E-06 |
| Normal-vs-Stage4 |
7.91589999999953E-05 |
| Stage1-vs-Stage2 |
1.312810E-01 |
| Stage1-vs-Stage3 |
3.797400E-01 |
| Stage1-vs-Stage4 |
5.527000E-01 |
| Stage2-vs-Stage3 |
5.430100E-02 |
| Stage2-vs-Stage4 |
1.007190E-01 |
| Stage3-vs-Stage4 |
9.395000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.51160000025652E-07 |
| Normal-vs-AfricanAmerican |
2.263600E-01 |
| Normal-vs-Asian |
9.622900E-04 |
| Caucasian-vs-AfricanAmerican |
3.546000E-02 |
| Caucasian-vs-Asian |
8.322400E-01 |
| AfricanAmerican-vs-Asian |
1.268810E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.84479999954368E-08 |
| Normal-vs-Female |
1.625280E-04 |
| Male-vs-Female |
1.540470E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.57379999999564E-05 |
| Normal-vs-Age(41-60Yrs) |
5.59769999999293E-05 |
| Normal-vs-Age(61-80Yrs) |
1.184810E-04 |
| Normal-vs-Age(81-100Yrs) |
1.516060E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.155800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.322800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.745000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.565000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.966800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.105200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.823700E-03 |
| Classical-VS-Follicular |
8.589400E-01 |
| Classical-VS-Other |
6.014300E-02 |
| Classical-VS-Normal |
1.220870E-04 |
| Tall-VS-Follicular |
3.210200E-02 |
| Tall-VS-Other |
3.966600E-01 |
| Tall-VS-Normal |
6.17430000016128E-07 |
| Follicular-VS-Other |
1.361370E-01 |
| Follicular-VS-Normal |
2.495500E-03 |
| Other-VS-Normal |
1.741140E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.045400E-04 |
| Normal-vs-N1 |
9.05050000055141E-07 |
| N0-vs-N1 |
7.368000E-02 |
|
|
